Related Experiment Video
Updated: Jan 21, 2026

Monitoring Stub1-Mediated Pexophagy
Published on: May 12, 2023
STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling
Dong-E Tang1, Yong Dai1, Lie-Wen Lin1
1Department of Clinical Medical Research Center, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital Southern, University of Science and Technology, Shenzhen People's Hospital, Shenzhen, China.
Abstract:
Yes-associated protein (YAP) is a component of the canonical Hippo signaling pathway that is known to play essential roles in modulating organ size, development, and tumorigenesis. Activation or upregulation of YAP1, which contributes to cancer cell survival and chemoresistance, has been verified in different types of human cancers. However, the molecular mechanism of YAP1 upregulation in cancer is still unclear. Here we report that the E3 ubiquitin ligase STUB1 ubiquitinates and destabilizes YAP1, thereby inhibiting cancer cell survival. Low levels of STUB1 expression were correlated with increased protein levels of YAP1 in human gastric cancer cell lines and patient samples. Moreover, we revealed that STUB1 ubiquitinates YAP1 at the K280 site by K48-linked polyubiquitination, which in turn increases YAP1 turnover and promotes cellular chemosensitivity. Overall, our study establishes YAP1 ubiquitination and degradation mediated by the E3 ligase STUB1 as an important regulatory mechanism in gastric cancer, and provides a rationale for potential therapeutic interventions.
Insights
The E3 ubiquitin ligase STUB1 targets YAP1 for degradation, inhibiting cancer cell survival. Lower STUB1 levels correlate with higher YAP1, impacting gastric cancer progression and chemosensitivity.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Yes-associated protein (YAP) is crucial for organ size and tumorigenesis.
- YAP1 activation promotes cancer cell survival and chemoresistance.
- The mechanism of YAP1 upregulation in cancer remains largely unknown.
Purpose of the Study:
- To elucidate the molecular mechanism regulating YAP1 levels in cancer.
- To investigate the role of E3 ubiquitin ligases in YAP1 stability.
- To explore STUB1 as a potential therapeutic target in gastric cancer.
Main Methods:
- Western blotting to assess protein levels of YAP1 and STUB1.
- Ubiquitination assays to identify YAP1 ubiquitination sites.
- Immunoprecipitation to confirm STUB1-YAP1 interaction.
- Analysis of human gastric cancer cell lines and patient samples.
Main Results:
- STUB1 directly ubiquitinates and destabilizes YAP1.
- STUB1-mediated ubiquitination occurs at the K280 site via K48-linked polyubiquitination.
- Low STUB1 expression correlates with high YAP1 levels in gastric cancer.
- STUB1 promotes YAP1 turnover, enhancing cellular chemosensitivity.
Conclusions:
- STUB1-mediated YAP1 degradation is a key regulatory mechanism in gastric cancer.
- This pathway impacts cancer cell survival and response to chemotherapy.
- Targeting STUB1-YAP1 interaction offers a potential therapeutic strategy for gastric cancer.
More Related Videos
Related Concept Videos
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
What is Cell Signaling?
Endocrine Signaling
Bacterial Signaling
Paracrine Signaling

